Medivir AB (publ) (LON:0GP7)

Medivir AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	17	23	12	44	51	18
Market Cap Growth	85.09%	85.09%	-71.72%	-13.83%	183.67%	-26.18%
Enterprise Value	13	17	9	34	34	11
Last Close Price	0.15	0.20	0.26	0.52	0.64	0.92
PS Ratio	91.02	91.02	20.85	125.15	19.27	9.86
PB Ratio	2.76	2.76	0.73	2.86	2.22	1.42
P/TBV Ratio	2.76	2.76	0.73	2.86	2.22	1.42
EV/Sales Ratio	50.62	67.30	14.40	96.27	12.69	5.81
Debt / Equity Ratio	0.07	0.07	0.06	0.08	0.05	0.12
Asset Turnover	0.02	0.02	0.03	0.02	0.12	0.08
Quick Ratio	1.37	1.37	3.03	4.37	5.40	2.24
Current Ratio	1.37	1.37	3.05	4.39	5.42	2.28
Return on Equity (ROE)	-73.96%	-73.96%	-43.50%	-37.46%	-29.84%	-26.12%
Return on Assets (ROA)	-34.83%	-34.83%	-22.21%	-19.43%	-15.27%	-15.68%
Return on Capital (ROIC)	-45.10%	-45.10%	-26.36%	-22.00%	-17.75%	-19.66%
Earnings Yield	-51.82%	-38.71%	-56.14%	-16.09%	-10.11%	-21.15%
FCF Yield	-38.99%	-38.99%	-37.50%	-18.53%	-7.81%	-30.14%
Buyback Yield / Dilution	-88.71%	-88.71%	-8.44%	-5.53%	-117.45%	-
Total Shareholder Return	-88.71%	-88.71%	-8.44%	-5.53%	-117.45%	-

Source: S&P Capital IQ. Standard template. Financial Sources.